In past one week, the stock of pharmaceuticals Company surged 30% from Rs 260, as compared to 1.6% rise in the S&P BSE Sensex.
On clarification of news report, Unichem Laboratories on Tuesday said that as and when an obligation arises, rest assured an announcement will be made.
“We wish to state that nothing has occurred that requires complaint reporting or confirmation of any development. At this stage any further comment would fuel speculation and would itself be violation of regulatory obligations,” it added.
At 11:49 AM; the stock was up 9% at Rs 331 on the BSE, as compared to 1.1% rise in the S&P BSE Sensex. The trading volumes on the counter nearly doubled with a combined 769,242 shares changed hands on the BSE and NSE so far.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in